These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 20697760)
1. Structure-based in-silico rational design of a selective peptide inhibitor for thymidine monophosphate kinase of mycobacterium tuberculosis. Kumar M; Sharma S; Srinivasan A; Singh TP; Kaur P J Mol Model; 2011 May; 17(5):1173-82. PubMed ID: 20697760 [TBL] [Abstract][Full Text] [Related]
2. Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Frecer V; Seneci P; Miertus S J Comput Aided Mol Des; 2011 Jan; 25(1):31-49. PubMed ID: 21082329 [TBL] [Abstract][Full Text] [Related]
3. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents. Song L; Risseeuw MDP; Froeyen M; Karalic I; Goeman J; Cappoen D; Van der Eycken J; Cos P; Munier-Lehmann H; Van Calenbergh S Bioorg Med Chem; 2016 Nov; 24(21):5172-5182. PubMed ID: 27614917 [TBL] [Abstract][Full Text] [Related]
4. Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Vanheusden V; Munier-Lehmann H; Froeyen M; Busson R; Rozenski J; Herdewijn P; Van Calenbergh S J Med Chem; 2004 Dec; 47(25):6187-94. PubMed ID: 15566289 [TBL] [Abstract][Full Text] [Related]
5. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors. Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716 [TBL] [Abstract][Full Text] [Related]
6. The crystal structure of Mycobacterium tuberculosis thymidylate kinase in complex with 3'-azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition. Fioravanti E; Adam V; Munier-Lehmann H; Bourgeois D Biochemistry; 2005 Jan; 44(1):130-7. PubMed ID: 15628853 [TBL] [Abstract][Full Text] [Related]
7. Rational design of 5'-thiourea-substituted alpha-thymidine analogues as thymidine monophosphate kinase inhibitors capable of inhibiting mycobacterial growth. Van Daele I; Munier-Lehmann H; Froeyen M; Balzarini J; Van Calenbergh S J Med Chem; 2007 Nov; 50(22):5281-92. PubMed ID: 17910427 [TBL] [Abstract][Full Text] [Related]
9. In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery. Kumar M; Vijayakrishnan R; Subba Rao G Mol Divers; 2010 Aug; 14(3):595-604. PubMed ID: 19697148 [TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods. Aparna V; Jeevan J; Ravi M; Desiraju GR; Gopalakrishnan B Bioorg Med Chem Lett; 2006 Feb; 16(4):1014-20. PubMed ID: 16290929 [TBL] [Abstract][Full Text] [Related]
11. Structural and chemical basis for enhanced affinity to a series of mycobacterial thymidine monophosphate kinase inhibitors: fragment-based QSAR and QM/MM docking studies. Bueno RV; Toledo NR; Neves BJ; Braga RC; Andrade CH J Mol Model; 2013 Jan; 19(1):179-92. PubMed ID: 22846924 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Vanheusden V; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S Bioorg Med Chem Lett; 2002 Oct; 12(19):2695-8. PubMed ID: 12217356 [TBL] [Abstract][Full Text] [Related]
13. Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Vanheusden V; Van Rompaey P; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S Bioorg Med Chem Lett; 2003 Sep; 13(18):3045-8. PubMed ID: 12941330 [TBL] [Abstract][Full Text] [Related]
14. 1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors. Jian Y; Hulpia F; D P Risseeuw M; Forbes HE; Caljon G; Munier-Lehmann H; I M Boshoff H; Van Calenbergh S Molecules; 2020 Jun; 25(12):. PubMed ID: 32560578 [TBL] [Abstract][Full Text] [Related]
15. 3'-C-branched-chain-substituted nucleosides and nucleotides as potent inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Vanheusden V; Munier-Lehmann H; Froeyen M; Dugué L; Heyerick A; De Keukeleire D; Pochet S; Busson R; Herdewijn P; Van Calenbergh S J Med Chem; 2003 Aug; 46(18):3811-21. PubMed ID: 12930144 [TBL] [Abstract][Full Text] [Related]
16. Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate Kinase Inhibitors. Song L; Merceron R; Gracia B; Quintana AL; Risseeuw MDP; Hulpia F; Cos P; Aínsa JA; Munier-Lehmann H; Savvides SN; Van Calenbergh S J Med Chem; 2018 Apr; 61(7):2753-2775. PubMed ID: 29510037 [TBL] [Abstract][Full Text] [Related]
17. 3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents. Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ J Comput Aided Mol Des; 2010 Feb; 24(2):157-72. PubMed ID: 20217185 [TBL] [Abstract][Full Text] [Related]
18. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Gasse C; Huteau V; Douguet D; Munier-Lehmann H; Pochet S Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536 [No Abstract] [Full Text] [Related]
19. Computational Overview of Mycobacterial Thymidine Monophosphate Kinase. Gul S; Khalil R; Zaheer Ul-Haq ; Mubarak MS Curr Pharm Des; 2020; 26(15):1676-1681. PubMed ID: 32242781 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase. Van Poecke S; Munier-Lehmann H; Helynck O; Froeyen M; Van Calenbergh S Bioorg Med Chem; 2011 Dec; 19(24):7603-11. PubMed ID: 22061826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]